Preview
In their exploration of immunologic techniques for diagnosing and treating cancer, researchers have come upon a valuable ally—monoclonal antibodies. These immunoglobulins have definite potential in a variety of clinical applications related to tumor diagnosis and treatment, including differentiation of histologic subtypes, determination of prognosis, and growth inhibition. Dr Rosen and his associates explain what monoclonal antibodies are, how they are produced, and when we can expect to benefit from their clinical applications.